These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10773177)

  • 1. Placebo-controlled trials in psychiatric research: an ethical perspective.
    Miller FG
    Biol Psychiatry; 2000 Apr; 47(8):707-16. PubMed ID: 10773177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trials: Ethical and scientific issues in the choice of placebo or active control.
    Ovosi JO; Ibrahim MS; Bello-Ovosi BO
    Ann Afr Med; 2017; 16(3):97-100. PubMed ID: 28671148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled trials in schizophrenia: are they ethical? Are they necessary?
    Weijer C
    Schizophr Res; 1999 Feb; 35(3):211-8; discussion 227-36. PubMed ID: 10093865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebos and paradoxes in psychiatric research: an ethics perspective.
    Roberts LW; Lauriello J; Geppert C; Keith SJ
    Biol Psychiatry; 2001 Jun; 49(11):887-93. PubMed ID: 11377406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What makes placebo-controlled trials unethical?
    Miller FG; Brody H
    Am J Bioeth; 2002; 2(2):3-9. PubMed ID: 12189059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatry. Are placebo-controlled drug trials ethical?
    Enserink M
    Science; 2000 Apr; 288(5465):416. PubMed ID: 10798970
    [No Abstract]   [Full Text] [Related]  

  • 7. The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective.
    Laughren TP
    Eur Psychiatry; 2001 Nov; 16(7):418-23. PubMed ID: 11728855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo control groups in randomized treatment trials: a statistician's perspective.
    Lavori PW
    Biol Psychiatry; 2000 Apr; 47(8):717-23. PubMed ID: 10773178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases.
    Ellenberg SS; Temple R
    Ann Intern Med; 2000 Sep; 133(6):464-70. PubMed ID: 10975965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and burdens of placebos in psychiatric research.
    Kim SY
    Psychopharmacology (Berl); 2003 Dec; 171(1):13-8. PubMed ID: 12684741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo or active control trials of antipsychotic drugs?
    Fleischhacker WW; Czobor P; Hummer M; Kemmler G; Kohnen R; Volavka J
    Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues.
    Temple R; Ellenberg SS
    Ann Intern Med; 2000 Sep; 133(6):455-63. PubMed ID: 10975964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of placebo control groups in the assessment of psychiatric drugs: an historical context.
    Leber P
    Biol Psychiatry; 2000 Apr; 47(8):699-706. PubMed ID: 10773176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are placebo-controlled trials still important for obsessive compulsive disorder?
    Fineberg NA; Hawley CJ; Gale TM
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):413-22. PubMed ID: 16413647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo-free designs for evaluating new mental health treatments: the use of adaptive treatment strategies.
    Dawson R; Lavori PW
    Stat Med; 2004 Nov; 23(21):3249-62. PubMed ID: 15490427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo-controlled studies in schizophrenia--ethical and scientific perspectives: an overview of conference proceedings.
    Zipursky RB; Darby P
    Schizophr Res; 1999 Feb; 35(3):189-200. PubMed ID: 10093863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical framework for the use of sham procedures in clinical trials.
    Horng S; Miller FG
    Crit Care Med; 2003 Mar; 31(3 Suppl):S126-30. PubMed ID: 12626957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ethical implications of placebo-controlled clinical trials for psychotropic drugs].
    Helmchen H
    Nervenarzt; 2005 Nov; 76(11):1319-29. PubMed ID: 15812676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebos in clinical trials of psychotropic medication.
    Addington D; Williams R; Lapierre Y; el-Guebaly N
    Can J Psychiatry; 1997 Apr; 42(3):6p.. PubMed ID: 9114950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for the use of placebo controls in clinical trials of psychopharmacologic agents. Loma Linda University Institutional Review Board.
    Orr RD
    Psychiatr Serv; 1996 Nov; 47(11):1262-4. PubMed ID: 8916249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.